Literature DB >> 22978387

Clinical and immunophenotypic features of atypical complete DiGeorge syndrome.

Quang Van Vu1, Taizo Wada, Tomoko Toma, Hanako Tajima, Miho Maeda, Risa Tanaka, Tsutomu Oh-Ishi, Akihiro Yachie.   

Abstract

BACKGROUND: DiGeorge syndrome is a congenital malformation characterized by variable defects of the thymus, heart and parathyroid glands. Athymic patients are classified as exhibiting complete DiGeorge syndrome. Some of these patients may also exhibit oligoclonal T-cell expansion, generalized rash and lymphadenopathy at some point after birth. This rare condition is known as atypical complete DiGeorge syndrome, resembles Omenn syndrome, and has not been fully characterized.
METHODS: The clinical and immunophenotypic features of atypical complete DiGeorge syndrome were assessed in two affected Japanese infants. T-cell receptor (TCR) Vβ repertoire was analyzed on flow cytometry and complementarity-determining region 3 spectratyping.
RESULTS: Both patients had no detectable thymus tissue and profound T-cell lymphopenia soon after birth. Progressive increase of activated T cells, however, as well as eosinophilia, high serum IgE level, generalized rash, and lymphadenopathy were observed during early infancy. A highly restricted TCR Vβ repertoire was demonstrated both in CD4(+) and CD8(+) T cells.
CONCLUSIONS: The Omenn syndrome-like manifestations might be associated with the oligoclonal proliferation of activated T cells. Analysis of the immunophenotype and TCR Vβ repertoire is helpful to establish the early diagnosis of atypical complete DiGeorge syndrome.
© 2012 The Authors. Pediatrics International © 2012 Japan Pediatric Society.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22978387     DOI: 10.1111/j.1442-200X.2012.03722.x

Source DB:  PubMed          Journal:  Pediatr Int        ISSN: 1328-8067            Impact factor:   1.524


  8 in total

Review 1.  Eosinophilia Associated with Disorders of Immune Deficiency or Immune Dysregulation.

Authors:  Kelli W Williams; Joshua D Milner; Alexandra F Freeman
Journal:  Immunol Allergy Clin North Am       Date:  2015-08       Impact factor: 3.479

Review 2.  Genetics of allergy and allergic sensitization: common variants, rare mutations.

Authors:  Klaus Bønnelykke; Rachel Sparks; Johannes Waage; Joshua D Milner
Journal:  Curr Opin Immunol       Date:  2015-09-18       Impact factor: 7.486

Review 3.  Congenital Athymia: Genetic Etiologies, Clinical Manifestations, Diagnosis, and Treatment.

Authors:  Cathleen Collins; Emily Sharpe; Abigail Silber; Sarah Kulke; Elena W Y Hsieh
Journal:  J Clin Immunol       Date:  2021-05-13       Impact factor: 8.317

Review 4.  Primary immunodeficiencies associated with eosinophilia.

Authors:  Behdad Navabi; Julia Elizabeth Mainwaring Upton
Journal:  Allergy Asthma Clin Immunol       Date:  2016-05-24       Impact factor: 3.406

Review 5.  Unbalanced Immune System: Immunodeficiencies and Autoimmunity.

Authors:  Giuliana Giardino; Vera Gallo; Rosaria Prencipe; Giovanni Gaudino; Roberta Romano; Marco De Cataldis; Paola Lorello; Loredana Palamaro; Chiara Di Giacomo; Donatella Capalbo; Emilia Cirillo; Roberta D'Assante; Claudio Pignata
Journal:  Front Pediatr       Date:  2016-10-06       Impact factor: 3.418

Review 6.  FOXN1 deficient nude severe combined immunodeficiency.

Authors:  Ioanna A Rota; Fatima Dhalla
Journal:  Orphanet J Rare Dis       Date:  2017-01-11       Impact factor: 4.123

Review 7.  Diagnostic Challenges in Patients with Inborn Errors of Immunity with Different Manifestations of Immune Dysregulation.

Authors:  Karolina Pieniawska-Śmiech; Gerard Pasternak; Aleksandra Lewandowicz-Uszyńska; Marek Jutel
Journal:  J Clin Med       Date:  2022-07-20       Impact factor: 4.964

8.  T-cell receptor phenotype pattern in atopic children using commercial fluorescently labeled antibodies against 21 human class-specific v segments for the tcrβ chain (vβ) of peripheral blood: a cross sectional study.

Authors:  Gassem Gohal; Christine McCusker; Bruce Mazer; Reza Alizadehfar; Duncan Lejtenyi; Moshe Ben-Shoshan
Journal:  Allergy Asthma Clin Immunol       Date:  2016-03-02       Impact factor: 3.406

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.